Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00794612 | Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability. | PHASE3 | COMPLETED | 30 | — | — | Nov 1, 2008 | - | Dec 19, 2008 | 1 | Brazil |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd Femina Pocket BR (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd Femina Pocket BR (Lactic Acid) | DRUG | Dermacyd Femina Pocket BR (Lactic Acid) during 21 consecutive days |
Inclusion criteria: * Integral skin test in the region; * To use products of the same category; Exclusion criteria: * Lactation or gestation; * Use of anti-inflammatory, anti-histaminic or immunosuppressant drugs; * Cutaneous disease (local or spread) in the evaluation area; * Pathology which may...